Respiratory acidosis is a primary acid-base disorder resulting from an increase in arterial PaCO₂ (>45 mmHg) due to alveolar hypoventilation, leading to acidemia (pH <7.35 in acute cases). [1-2] It develops from disorders affecting gas exchange, chest wall/respiratory muscles, or inhibition of the medullary respiratory center. [1] The following figure illustrates the pathophysiological progression from acute to chronic respiratory acidosis and the risk of posthypercapnic alkalosis with overly rapid correction.
1. History
- Key HPI questions: Onset and tempo of dyspnea, orthopnea, sleep quality (snoring, witnessed apneas, morning headaches), medication/substance use (opioids, benzodiazepines, alcohol), recent illness or infection, trauma
- Symptom characterization: Sleepiness, morning headaches, general tiredness, malaise, ankle edema, confusion [4]
- Timing: Acute (hours–days) vs. chronic (weeks–months); acute-on-chronic decompensation is common in COPD [4]
- Triggers: Infection, sedating medications, oxygen over-supplementation in CO₂ retainers, postoperative state, neuromuscular flare
- Important negatives: Absence of chest pain, hemoptysis, fever, focal neurologic deficits, toxic ingestion
2. Alarm Features
- pH <7.25 — severe acidemia with high risk of cardiovascular collapse and NIV failure [5]
- Rapidly declining mental status — confusion, somnolence, or coma indicating CO₂ narcosis [2][4]
- Respiratory rate <8 or >30 with accessory muscle use, abdominal paradox, or inability to speak in full sentences [6]
- Hemodynamic instability — hypotension unresponsive to fluids [5]
- Coexistent metabolic acidemia (low base excess) — mixed acidosis portends worse outcomes [5]
- Inability to protect airway or clear secretions — absolute contraindication to NIV, mandates intubation [6]
- Late-onset hypercapnia developing after hospital admission despite primary therapy [5]
3. Medications
Causative medications (CNS/respiratory depression)
- Opioids, benzodiazepines, barbiturates, general anesthetics, muscle relaxants
- Excessive supplemental O₂ in chronic CO₂ retainers (blunts hypoxic drive) [4]
Treatment medications
- Inhaled bronchodilators (albuterol, ipratropium) and systemic corticosteroids for obstructive etiologies [4]
- Naloxone for opioid-induced hypoventilation; flumazenil for benzodiazepine overdose (use with caution — seizure risk)
- Acetazolamide — carbonic anhydrase inhibitor that promotes renal bicarbonate excretion, may augment ventilatory drive in chronic compensated respiratory acidosis (e.g., COPD, OHS) [7]
Contraindicated/caution
- Sodium bicarbonate is not recommended for isolated respiratory acidosis — no RCT evidence of benefit and potential risks including paradoxical intracellular acidosis and volume overload. May be considered only in mixed respiratory + metabolic acidosis or permissive hypercapnia with severe acidemia [8-10]
- Avoid sedatives, opioids, and neuromuscular blockers unless intubation is planned
4. Diet
- High-carbohydrate diets increase CO₂ production (RQ ~1.0 for carbohydrates vs. ~0.7 for fat); in ventilator-dependent or borderline patients, high-fat/low-carb enteral formulas may reduce CO₂ load [1]
- Adequate hydration to support mucociliary clearance
- In obesity hypoventilation syndrome (OHS), long-term weight management is a cornerstone of therapy
5. Review of Systems
- Pulmonary: Dyspnea, cough, sputum production, wheezing, orthopnea, exercise intolerance
- Neurologic: Headache (especially morning), somnolence, confusion, tremor, asterixis, seizures [2]
- Cardiovascular: Peripheral edema, palpitations (arrhythmias from acidemia/hypercapnia)
- Psychiatric: Anxiety, panic, insomnia (or hypersomnia)
- Musculoskeletal: Weakness, fatigue (neuromuscular disease screening)
6. Collateral History and Family History
- Collateral: Witnessed apneas, snoring, baseline functional status, home O₂ or CPAP/BiPAP use, prior intubations, recent medication changes, substance use
- Family history: Neuromuscular diseases (muscular dystrophy, myasthenia gravis), COPD, obesity, obstructive sleep apnea [4]
- Social context: Smoking history, occupational exposures, home environment (ability to use NIV at home), access to follow-up
7. Risk Factors
- COPD — most common cause of chronic respiratory acidosis [2][11]
- Obesity/OHS — restrictive physiology with blunted ventilatory drive [4]
- Neuromuscular disease — ALS, muscular dystrophy, myasthenia gravis, Guillain-Barré syndrome [4]
- CNS depression — drug overdose (opioids, benzodiazepines), stroke, brainstem lesions [2]
- Chest wall deformity — severe kyphoscoliosis [4]
- Severe asthma — status asthmaticus with air trapping
- Obstructive sleep apnea — especially when combined with obesity
- Metabolic abnormalities — severe hypokalemia, hypothyroidism (myxedema) [4]
8. Differential Diagnosis
- COPD exacerbation — most common cause; look for wheezing, prolonged expiratory phase, smoking history
- Opioid/sedative overdose — pinpoint pupils, depressed RR, toxicology screen
- Severe asthma (status asthmaticus) — rising PaCO₂ is a late and ominous sign
- Neuromuscular crisis — Guillain-Barré, myasthenic crisis; ascending weakness, bulbar symptoms
- Obesity hypoventilation syndrome — BMI >30, daytime hypercapnia, often with OSA
- Pulmonary edema (cardiogenic or ARDS) — may cause mixed respiratory failure
- Pneumothorax — sudden onset, unilateral absent breath sounds
- CNS event — brainstem stroke, intracranial hemorrhage affecting respiratory centers
- Metabolic acidosis with respiratory fatigue — distinguish from primary respiratory acidosis by ABG pattern [11]
9. Past Medical History
- Prior episodes of hypercapnic respiratory failure, prior intubations
- Baseline PaCO₂ and HCO₃⁻ (critical for distinguishing acute vs. chronic vs. acute-on-chronic)
- COPD severity (GOLD stage), home O₂ use, home NIV/CPAP
- Neuromuscular diagnoses, chest wall abnormalities
- Cardiac comorbidities (heart failure, pulmonary hypertension)
- Surgical history (thoracic, abdominal — diaphragmatic dysfunction)
10. Physical Exam
Vital signs
- Tachypnea (>24 in obstructive, >30 in restrictive) or paradoxically low RR in CNS depression [6]
- Tachycardia, hypertension (sympathetic response to hypercapnia), or hypotension in severe cases
- SpO₂ may be normal or low; SpO₂ does not reflect CO₂ levels
Focused exam
- Pulmonary: Wheezing, prolonged expiration, diminished breath sounds, accessory muscle use, abdominal paradox (diaphragm fatigue)
- Neurologic: Altered mental status, asterixis, papilledema (from cerebral vasodilation), tremor [2]
- Cardiovascular: Bounding pulses, flushed skin, peripheral edema, elevated JVP (cor pulmonale) [4]
- Musculoskeletal: Proximal weakness, kyphoscoliosis, obesity habitus
11. Lab Studies
Essential
- Arterial blood gas (ABG) — gold standard; defines pH, PaCO₂, PaO₂, HCO₃⁻, base excess [4]
- Acute: HCO₃⁻ rises ~1 mEq/L per 10 mmHg rise in PaCO₂
- Chronic: HCO₃⁻ rises ~3.5–4 mEq/L per 10 mmHg rise in PaCO₂ [12]
- Venous blood gas (VBG) — reasonable screen; venous PCO₂ correlates with arterial values and can rule out significant hypercarbia [4]
- Basic metabolic panel — serum HCO₃⁻, electrolytes (K⁺, Cl⁻), BUN/Cr, glucose
- CBC — infection screening
- Lactate — assess tissue perfusion
Situational
- Toxicology screen — if overdose suspected
- TSH — if myxedema suspected
- BNP/NT-proBNP — if heart failure contributing
- Phosphate, magnesium — neuromuscular function
12. Imaging
- Chest X-ray — first-line; evaluate for pneumonia, pulmonary edema, pneumothorax, pleural effusion, hyperinflation (COPD), kyphoscoliosis [2]
- CT chest — if PE suspected, mass lesion, or CXR inconclusive
- CT head — if CNS etiology suspected (brainstem stroke, hemorrhage)
- Imaging is unnecessary if the etiology is clearly established (e.g., known opioid overdose with response to naloxone)
13. Special Tests
- A-a gradient — helps distinguish intrinsic lung disease (elevated A-a gradient) from pure hypoventilation (normal A-a gradient) [13]
- Pulmonary function tests (PFTs) — outpatient; assess severity of obstructive/restrictive disease
- Negative inspiratory force (NIF) and vital capacity — bedside assessment of neuromuscular respiratory reserve (NIF worse than −20 cmH₂O or VC <15 mL/kg suggests impending respiratory failure)
- Polysomnography — outpatient for suspected OSA/OHS
- Point-of-care ultrasound — diaphragm excursion, B-lines (pulmonary edema), pleural effusion, cardiac function
14. ECG
- Indications: All patients with acute respiratory acidosis to assess for arrhythmia and cardiac comorbidity
- Findings to watch for:
- Sinus tachycardia (most common)
- Atrial fibrillation (associated with worse outcomes in COPD exacerbation) [5]
- Right heart strain pattern (P pulmonale, right axis deviation, RV hypertrophy) — suggests chronic cor pulmonale
- Peaked T waves — hyperkalemia from severe acidemia
- Widened QRS or arrhythmias — severe acidemia (pH <7.1)
15. Assessment
Severity stratification
- Mild: pH 7.30–7.35, PaCO₂ 45–60 mmHg — may respond to medical therapy alone
- Moderate: pH 7.25–7.30, PaCO₂ 60–80 mmHg — strong indication for NIV [5]
- Severe: pH <7.25 — high risk of NIV failure, prepare for intubation [5]
Acute vs. chronic vs. acute-on-chronic
- Acute: SBE = 0 ± 2 mEq/L (no renal compensation yet) [12]
- Chronic: SBE = 0.4 × (PaCO₂ − 40); HCO₃⁻ elevated proportionally [12]
- Acute-on-chronic: Compensation present but insufficient for degree of hypercapnia — most common ED presentation in COPD [4]
Complications: CO₂ narcosis, cardiac arrhythmias, cardiovascular collapse, posthypercapnic metabolic alkalosis (if corrected too rapidly) [3]
16. Treatment Plan
Initial stabilization
- Airway assessment — if unable to protect airway → intubate
- Controlled oxygen therapy — target SpO₂ 88–92% in known CO₂ retainers; avoid high-flow O₂ which may worsen hypercapnia [14]
Non-invasive ventilation (NIV)
- First-line for acute hypercapnic respiratory failure with pH <7.35 and PaCO₂ >45 mmHg [5-6]
- BiPAP: typical starting settings IPAP 10–12 cmH₂O, EPAP 4–5 cmH₂O; titrate to clinical response
- Repeat ABG at 1–2 hours to assess response; improvement in pH and PaCO₂ expected [4]
- Contraindications to NIV: Cardiac/respiratory arrest, inability to protect airway, copious secretions, hemodynamic instability, facial trauma/surgery [6]
Etiology-directed therapy
- COPD exacerbation: Bronchodilators (albuterol/ipratropium), systemic corticosteroids, antibiotics if indicated [4]
- Opioid overdose: Naloxone 0.4–2 mg IV, repeat as needed
- Neuromuscular crisis: Urgent neurology consultation; plasmapheresis/IVIG for myasthenic crisis or GBS
- Status asthmaticus: Aggressive bronchodilators, IV magnesium, consider ketamine for sedation if intubating
Invasive mechanical ventilation
- If NIV fails (worsening pH, rising PaCO₂, declining mental status) or contraindicated
- In chronic hypercapnia, target the patient's baseline PaCO₂, not normal values — rapid correction risks posthypercapnic alkalosis [3]
Sodium bicarbonate: Not recommended for isolated respiratory acidosis; may be considered for mixed respiratory + metabolic acidosis with severe acidemia [8][10]
Acetazolamide: May be used as adjunct in chronic compensated respiratory acidosis to promote bicarbonate excretion and augment ventilatory drive [7]
17. Disposition
- ICU admission: pH <7.25, hemodynamic instability, altered mental status, need for intubation, NIV failure, rapidly worsening trajectory [5][15]
- Stepdown/telemetry admission: pH 7.25–7.35 on NIV with improving trend, stable hemodynamics, new supplemental O₂ requirement [15]
- Observation: Mild respiratory acidosis responding to medical therapy, stable on room air or baseline O₂
- Discharge: Rarely appropriate for acute respiratory acidosis; consider only if etiology is fully reversed (e.g., opioid overdose with sustained response to naloxone, no recurrence after observation period), patient returns to baseline, and reliable follow-up is ensured [15]
- Specialist consultation triggers: Pulmonology (COPD, OHS, neuromuscular disease), neurology (GBS, myasthenic crisis), toxicology (complex overdose), palliative care (end-stage disease)
18. Follow Up / Return Precautions
- Follow-up timing: Pulmonology or PCP within 1–2 weeks of discharge; sooner if on new home NIV [15]
- Return precautions — instruct patients to return immediately for:
- Worsening shortness of breath or inability to speak in full sentences
- Increasing drowsiness, confusion, or difficulty waking
- New or worsening swelling in legs
- Fever or worsening cough with colored sputum
- Patient counseling:
- Smoking cessation (if applicable) [15]
- Medication adherence (inhalers, home NIV)
- Avoid sedating medications unless prescribed
- Weight management in OHS
- Expected recovery: Acute respiratory acidosis from reversible causes (e.g., COPD exacerbation) typically improves within 24–72 hours with appropriate therapy; chronic respiratory acidosis requires long-term management of the underlying condition
References
1. Respiratory Acidosis and Respiratory Alkalosis: Core Curriculum 2023. — Palmer BF, Clegg DJ. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2023.
2. Respiratory Acidosis. — Epstein SK, Singh N. Respiratory Care. 2001.
3. Management of Life-Threatening Acid–Base Disorders. — Adrogué HJ, Madias NE. The New England Journal of Medicine. 1998.
4. Peripheral Venous Blood Gas Analysis for the Diagnosis of Respiratory Failure, Hypercarbia and Metabolic Disturbance in Adults. — Byrne AL, Pace NL, Thomas PS, et al. The Cochrane Database of Systematic Reviews. 2025.
5. Beyond the Guidelines for Non-Invasive Ventilation in Acute Respiratory Failure: Implications for Practice. — Bourke SC, Piraino T, Pisani L, Brochard L, Elliott MW. The Lancet. Respiratory Medicine. 2018.
6. Non-Invasive Ventilation in Acute Respiratory Failure. — Nava S, Hill N. Lancet. 2009.
7. Carbonic Anhydrase Inhibitors for Hypercapnic Ventilatory Failure in Chronic Obstructive Pulmonary Disease. — Jones PW, Greenstone M. The Cochrane Database of Systematic Reviews. 2001.
8. Sodium Bicarbonate Therapy for Acute Respiratory Acidosis. — Chand R, Swenson ER, Goldfarb DS. Current Opinion in Nephrology and Hypertension. 2021.
9. Acid-Base Disorders in the Critically Ill Patient. — Achanti A, Szerlip HM. Clinical Journal of the American Society of Nephrology : CJASN. 2023.
10. Alkali Therapy for Respiratory Acidosis: A Medical Controversy. — Adrogué HJ, Madias NE. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2020.
11. Acid-Base Interpretation: A Practical Approach. — Morikawa MJ, Ganesh PR. American Family Physician. 2025.
12. Diagnostic Use of Base Excess in Acid–Base Disorders. — Berend K. The New England Journal of Medicine. 2018.
13. Physiological Approach to Assessment of Acid–Base Disturbances. — Berend K, de Vries AP, Gans RO. The New England Journal of Medicine. 2014.
14. Management of Severe COPD. — Wouters EF. Lancet. 2004.
15. Acute Care of Patients With Moderate Respiratory Distress: Recommendations From an American College of Emergency Physicians Expert Panel. — Baugh CW, Neuenschwander JF, Lenox J, et al. The Western Journal of Emergency Medicine. 2025.